These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18466766)

  • 1. Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of vector-specific neutralizing antibodies in rhesus macaques.
    Moriya C; Horiba S; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Matano T
    Biochem Biophys Res Commun; 2008 Jul; 371(4):850-4. PubMed ID: 18466766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Sendai viral vector vaccination is more immunogenic than intramuscular under pre-existing anti-vector antibodies.
    Moriya C; Horiba S; Kurihara K; Kamada T; Takahara Y; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Matano T
    Vaccine; 2011 Nov; 29(47):8557-63. PubMed ID: 21939708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of repeated Sendai viral vector vaccination in macaques.
    Kurihara K; Takahara Y; Nomura T; Ishii H; Iwamoto N; Takahashi N; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Moriya C; Matano T
    Microbes Infect; 2012 Nov; 14(13):1169-76. PubMed ID: 22884717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques.
    Takeda A; Igarashi H; Kawada M; Tsukamoto T; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Matano T
    Vaccine; 2008 Dec; 26(52):6839-43. PubMed ID: 18930099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
    Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M
    J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.
    Putnak R; Fuller J; VanderZanden L; Innis BL; Vaughn DW
    Am J Trop Med Hyg; 2003 Apr; 68(4):469-76. PubMed ID: 12875299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Gag-specific T-cell responses by therapeutic immunization with a Gag-expressing Sendai virus vector in macaques chronically infected with simian-human immunodeficiency virus.
    Kato M; Igarashi H; Takeda A; Sasaki Y; Nakamura H; Kano M; Sata T; Iida A; Hasegawa M; Horie S; Higashihara E; Nagai Y; Matano T
    Vaccine; 2005 May; 23(24):3166-73. PubMed ID: 15837216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Sendai virus vector induces complete remission of established brain tumors through efficient interleukin-2 gene transfer in vaccinated rats.
    Iwadate Y; Inoue M; Saegusa T; Tokusumi Y; Kinoh H; Hasegawa M; Tagawa M; Yamaura A; Shimada H
    Clin Cancer Res; 2005 May; 11(10):3821-7. PubMed ID: 15897582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
    Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
    Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
    Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
    Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary replication of a recombinant Sendai virus vector in macaques.
    Kano M; Matano T; Kato A; Nakamura H; Takeda A; Suzaki Y; Ami Y; Terao K; Nagai Y
    J Gen Virol; 2002 Jun; 83(Pt 6):1377-1386. PubMed ID: 12029153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
    Voges B; Vallbracht S; Zimmer G; Bossow S; Neubert WJ; Richter K; Hobeika E; Herrler G; Ehl S
    Cell Immunol; 2007 Jun; 247(2):85-94. PubMed ID: 17904538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designed recombinant adenovirus type 5 vector induced envelope-specific CD8(+) cytotoxic T lymphocytes and cross-reactive neutralizing antibodies against human immunodeficiency virus type 1.
    Ura T; Yoshida A; Xin KQ; Yoshizaki S; Yashima S; Abe S; Mizuguchi H; Okuda K
    J Gene Med; 2009 Feb; 11(2):139-49. PubMed ID: 19065543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Sendai virus vectors for activated T lymphocytes.
    Okano S; Yonemitsu Y; Nagata S; Sata S; Onimaru M; Nakagawa K; Tomita Y; Kishihara K; Hashimoto S; Nakashima Y; Sugimachi K; Hasegawa M; Sueishi K
    Gene Ther; 2003 Aug; 10(16):1381-91. PubMed ID: 12883535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.
    Schäffner JW; Dittmer U; Otteken A; Coulibaly C; Bodemer W; Voss G; Hunsmann G
    Am J Vet Res; 1994 Sep; 55(9):1250-5. PubMed ID: 7802392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice.
    Tanaka S; Yonemitsu Y; Yoshida K; Okano S; Kondo H; Inoue M; Hasegawa M; Masumoto K; Suita S; Taguchi T; Sueishi K
    Gene Ther; 2007 Jul; 14(13):1017-28. PubMed ID: 17460720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    Kaplan JM; St George JA; Pennington SE; Keyes LD; Johnson RP; Wadsworth SC; Smith AE
    Gene Ther; 1996 Feb; 3(2):117-27. PubMed ID: 8867859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.